[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@MarkC_LVB Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1026340653209276417.png) @MarkC_LVB Mark C

Mark C posts on X about $arwr, $alny, target, $prqr the most. They currently have XXX followers and XXX posts still getting attention that total XX engagements in the last XX hours.

### Engagements: XX [#](/creator/twitter::1026340653209276417/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1026340653209276417/c:line/m:interactions.svg)

- X Week XXX -XX%
- X Month XXXXXX +3,533%
- X Months XXXXXX +670%
- X Year XXXXXXX +256%

### Mentions: X [#](/creator/twitter::1026340653209276417/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1026340653209276417/c:line/m:posts_active.svg)


### Followers: XXX [#](/creator/twitter::1026340653209276417/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1026340653209276417/c:line/m:followers.svg)

- X Week XXX +1.10%
- X Month XXX +1.70%
- X Months XXX +4.20%
- X Year XXX +6.80%

### CreatorRank: undefined [#](/creator/twitter::1026340653209276417/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1026340653209276417/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[stocks](/list/stocks) 

**Social topic influence**
[$arwr](/topic/$arwr) #14, [$alny](/topic/$alny) #13, [target](/topic/target), [$prqr](/topic/$prqr), [$nvo](/topic/$nvo), [$lly](/topic/$lly), [$drna](/topic/$drna)

**Top accounts mentioned or mentioned by**
[@arrowheadpharma](/creator/undefined) [@rnaianalyst](/creator/undefined) [@towiu2](/creator/undefined) [@novavax](/creator/undefined) [@biohazard3737](/creator/undefined) [@sonichedgefund](/creator/undefined) [@artsstocks](/creator/undefined) [@erictopol](/creator/undefined) [@pnani456](/creator/undefined) [@semodough](/creator/undefined) [@bradloncar](/creator/undefined) [@ericldaugh](/creator/undefined) [@jmaraganore](/creator/undefined) [@ionisdisrupts](/creator/undefined) [@biotech2k1](/creator/undefined) [@lasvegaslocally](/creator/undefined) [@f1lasvegas](/creator/undefined) [@cfbnerds](/creator/undefined) [@ibdagatlin](/creator/undefined) [@deitaone](/creator/undefined)

**Top assets mentioned**
[Arrowhead Research Corporation (ARWR)](/topic/$arwr) [Alnylam Pharmaceuticals, Inc. (ALNY)](/topic/$alny) [Novo-Nordisk (NVO)](/topic/$nvo) [Eli Lilly and Company (LLY)](/topic/$lly)
### Top Social Posts
Top posts by engagements in the last XX hours

"This is how its done @JMaraganore was a pioneer in RNAi while $ARWR is main competitor for $ALNY still willing to recognize excellence and celebrate success for patients"  
[X Link](https://x.com/MarkC_LVB/status/1990835835118493882)  2025-11-18T17:33Z XXX followers, 5487 engagements


"What could be the next big Tech Whats more technology focused than the ability to program the human body to fight disease $ARWR can potentially target all significant disease processes and silence them. $ALNY $PRQR"  
[X Link](https://x.com/MarkC_LVB/status/1993732070724800970)  2025-11-26T17:22Z XXX followers, 1096 engagements


"@EliKorey While I still dont think BP can pay enough to satisfy $ARWR youd have to think $LLY is watching closely. As one of the few BP with the $$ and also major risk should INHBE succeed. In addition $NVO has RNAi assets from $DRNA while LLY does not"  
[X Link](https://x.com/MarkC_LVB/status/1998070108573626839)  2025-12-08T16:40Z XXX followers, XXX engagements